Accelerate Diagnostics (AXDX) Financials
$0.01
As on 13-Jun-2025 09:30EDT
Market cap
$1 Mln
Revenue (TTM)
$12 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Income Statement ($ Mln) |
TTM | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
11.59
|
11.70
|
12.06
|
12.75
|
11.78
|
11.17
|
|||||
|
Cost of Revenue
|
9.16
|
8.99
|
9.51
|
9.45
|
12.16
|
6.71
|
|||||
|
Gross Profit
|
2.43
|
2.70
|
2.55
|
3.30
|
-0.38
|
4.46
|
|||||
|
Operating Expenses
|
35.52
|
38.01
|
56.58
|
66.11
|
71.18
|
68.16
|
|||||
|
Operating Profit (EBIT)
|
-33.09
|
-35.31
|
-54.03
|
-62.81
|
-71.56
|
-63.70
|
|||||
|
Other Income
|
--
|
--
|
--
|
--
|
-6.10
|
-14.50
|
|||||
|
Profit before Tax
|
-45.54
|
-50.11
|
-60.77
|
-62.57
|
-77.66
|
-78.20
|
|||||
|
Provision for Tax
|
-0.13
|
-0.07
|
0.85
|
-0.08
|
0.05
|
0.01
|
|||||
|
Profit after Tax (Net Income)
|
-45.41
|
-50.05
|
-61.62
|
-62.49
|
-77.70
|
-78.21
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
--
|
--
|
--
|
-62.49
|
-77.70
|
-78.21
|
Liabilities ($ Mln) |
TTM | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
-56.04
|
-56.04
|
-19.89
|
-22.26
|
-35.07
|
-62.81
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
53.40
|
53.40
|
39.22
|
20.72
|
111.17
|
149.27
|
|||||
|
Current Liabilities
|
31.20
|
31.20
|
12.03
|
66.56
|
6.95
|
6.97
|
|||||
|
Total Liabilities
|
59.76
|
28.56
|
31.37
|
65.02
|
83.05
|
93.43
|
Assets ($ Mln) |
TTM | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
6.32
|
6.32
|
6.90
|
9.00
|
9.72
|
11.44
|
|||||
|
Current Assets
|
22.24
|
22.24
|
24.47
|
56.01
|
73.33
|
81.99
|
|||||
|
Total Assets
|
50.79
|
28.56
|
31.37
|
65.02
|
83.05
|
93.43
|
|||||
|
Total Debt*
|
66.58
|
66.58
|
39.22
|
77.54
|
111.11
|
149.98
|
|||||
|
Net Current Assets
|
--
|
-8.96
|
12.43
|
-10.54
|
66.39
|
75.02
|
Cashflow ($ Mln) |
TTM | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-24.19
|
-40.20
|
-48.73
|
-47.32
|
-50.39
|
|||||
|
Cash Flow from Investing Activities
|
--
|
--
|
--
|
12.42
|
8.30
|
13.61
|
|||||
|
Cash from Financing Activities
|
--
|
27.05
|
9.02
|
31.63
|
43.23
|
11.63
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
4.12
|
-25.23
|
Financials Ratios |
TTM | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash EPS ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Adjusted Book Value ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
Profitability Ratios |
TTM | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-335.11
|
-165.18
|
-95.18
|
-95.21
|
-73.14
|
|||||
|
ROE (%)
|
--
|
131.82
|
292.36
|
217.99
|
158.77
|
222.84
|
|||||
|
ROA (%)
|
-93.00
|
-167.03
|
-127.86
|
-84.41
|
-88.06
|
-68.65
|
|||||
|
EBIT Margin (%)
|
-262.10
|
-316.24
|
-439.71
|
-461.10
|
-527.18
|
-561.16
|
|||||
|
Net Margin (%)
|
-391.66
|
-427.81
|
-510.97
|
-490.06
|
-1,366.79
|
2,342.96
|
|||||
|
Cash Profit Margin (%)
|
0.00
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
TTM | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-4.51
|
-0.03
|
-0.05
|
0.08
|
0.06
|
0.20
|
|||||
|
EBIT Growth (%)
|
54.88
|
30.23
|
9.82
|
5.33
|
0.86
|
10.70
|
|||||
|
Net Profit Growth (%)
|
13.18
|
18.78
|
1.40
|
19.57
|
0.65
|
7.23
|
|||||
|
EPS Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Book Value Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
TTM | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
-1.10
|
-1.50
|
-0.52
|
-0.57
|
-0.80
|
-1.37
|
|||||
|
Close Price ($)
|
0.70
|
1.20
|
3.92
|
7.06
|
52.20
|
75.80
|
|||||
|
High Price ($)
|
2.09
|
4.24
|
11.90
|
55.90
|
156.00
|
191.10
|
|||||
|
Low Price ($)
|
0.69
|
0.73
|
3.72
|
4.64
|
40.10
|
45.30
|
|||||
|
Market Cap ($ Cr)
|
0.86
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
-1.19
|
-1.97
|
-3.48
|
-3.17
|
-2.39
|
|||||
|
Short term debt to equity ratio
|
-0.29
|
-0.29
|
-0.11
|
-2.62
|
-0.04
|
-0.02
|
|||||
|
Current Ratio
|
0.71
|
0.71
|
2.03
|
0.84
|
10.56
|
11.76
|
|||||
|
Quick Ratio
|
0.62
|
0.62
|
1.76
|
0.76
|
9.83
|
10.44
|
|||||
|
Interest Coverage
|
-2.01
|
-2.82
|
-6.85
|
-15.59
|
-4.00
|
-4.03
|
Operating Efficiency Ratios |
TTM | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
17.57
|
17.41
|
21.74
|
18.95
|
19.69
|
13.88
|
|||||
|
Asset Turnover
|
0.24
|
0.39
|
0.25
|
0.17
|
0.13
|
0.10
|
|||||
|
Receivable days
|
--
|
72.73
|
76.30
|
67.83
|
59.99
|
78.06
|
|||||
|
Inventory Days
|
--
|
125.12
|
163.32
|
198.32
|
214.46
|
470.45
|
|||||
|
Payable days
|
--
|
195.74
|
178.55
|
125.32
|
49.14
|
99.16
|
|||||
|
Cash Conversion Cycle
|
--
|
2.11
|
61.07
|
140.83
|
225.30
|
449.35
|